Rigel Pharmaceuticals (RIGL) Operating Income Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,386.07% |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | -6.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.95% |
| Dec 31, 2025 | 39.12% |
| Sep 30, 2025 | 102.19% |
| Jun 30, 2025 | 13,569.57% |
| Mar 31, 2025 | 283.36% |
| Dec 31, 2024 | 747.15% |
| Sep 30, 2024 | 414.80% |
| Jun 30, 2024 | 108.49% |
| Mar 31, 2024 | 45.26% |
| Dec 31, 2023 | -5.44% |
| Sep 30, 2023 | 75.74% |
| Jun 30, 2023 | 59.38% |
| Mar 31, 2023 | 51.54% |
| Dec 31, 2022 | 109.71% |
| Sep 30, 2022 | 6.99% |
| Jun 30, 2022 | 0.64% |
| Mar 31, 2022 | -162.89% |
| Dec 31, 2021 | -13.76% |
| Sep 30, 2021 | -43.57% |
| Jun 30, 2021 | 24.98% |
| Mar 31, 2021 | 98.58% |
| Dec 31, 2020 | -8.59% |
| Sep 30, 2020 | -14.49% |
| Jun 30, 2020 | 18.50% |
| Mar 31, 2020 | 214.41% |
| Dec 31, 2019 | -784.72% |
| Sep 30, 2019 | 50.61% |
| Jun 30, 2019 | 18.28% |
| Mar 31, 2019 | 25.70% |
| Dec 31, 2018 | 109.66% |
| Sep 30, 2018 | -36.49% |
| Jun 30, 2018 | -34.98% |
| Mar 31, 2018 | -52.66% |
| Dec 31, 2017 | -66.05% |
| Sep 30, 2017 | 21.48% |
| Jun 30, 2017 | -41.74% |
| Mar 31, 2017 | 7.77% |
| Dec 31, 2016 | -23.85% |
| Sep 30, 2016 | -235.33% |
| Jun 30, 2016 | 2.33% |
| Mar 31, 2016 | 3.69% |
| Dec 31, 2015 | 43.01% |
| Sep 30, 2015 | 67.77% |
| Jun 30, 2015 | 45.11% |
| Mar 31, 2015 | 18.51% |
| Dec 31, 2014 | -32.01% |
| Sep 30, 2014 | 12.08% |
| Jun 30, 2014 | -11.23% |
| Mar 31, 2014 | 12.93% |
| Dec 31, 2013 | 33.85% |
| Sep 30, 2013 | 6.41% |
| Jun 30, 2013 | 8.03% |
| Mar 31, 2013 | -10.30% |
| Dec 31, 2012 | 1.13% |
| Sep 30, 2012 | -41.73% |
| Jun 30, 2012 | -15.42% |
| Mar 31, 2012 | -11.74% |
| Dec 31, 2011 | -31.73% |
| Sep 30, 2011 | -135.83% |
| Jun 30, 2011 | -179.91% |